|
CH652145A5
(de)
|
1982-01-22 |
1985-10-31 |
Sandoz Ag |
Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
|
|
US4634666A
(en)
|
1984-01-06 |
1987-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human-murine hybridoma fusion partner
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
|
EP0307434B2
(en)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Altered antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
ES2139598T3
(es)
|
1990-07-10 |
2000-02-16 |
Medical Res Council |
Procedimientos para la produccion de miembros de parejas de union especifica.
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
JP2938569B2
(ja)
|
1990-08-29 |
1999-08-23 |
ジェンファーム インターナショナル，インコーポレイティド |
異種免疫グロブリンを作る方法及びトランスジェニックマウス
|
|
WO1993012227A1
(en)
|
1991-12-17 |
1993-06-24 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5871907A
(en)
|
1991-05-15 |
1999-02-16 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5858657A
(en)
|
1992-05-15 |
1999-01-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
CA2103059C
(en)
|
1991-06-14 |
2005-03-22 |
Paul J. Carter |
Method for making humanized antibodies
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
EP1136556B1
(en)
|
1991-11-25 |
2005-06-08 |
Enzon, Inc. |
Method of producing multivalent antigen-binding proteins
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US6005079A
(en)
|
1992-08-21 |
1999-12-21 |
Vrije Universiteit Brussels |
Immunoglobulins devoid of light chains
|
|
ATE427968T1
(de)
|
1992-08-21 |
2009-04-15 |
Univ Bruxelles |
Immunoglobuline ohne leichtkette
|
|
EP0672142B1
(en)
|
1992-12-04 |
2001-02-28 |
Medical Research Council |
Multivalent and multispecific binding proteins, their manufacture and use
|
|
ES2162863T3
(es)
|
1993-04-29 |
2002-01-16 |
Unilever Nv |
Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae.
|
|
DE69426527T2
(de)
|
1993-06-09 |
2001-08-30 |
Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno, Delft |
Verfahren zur herstellung von fusionsproteinen, die scfv fragmente enthalten, in transformierten schimmelpilzen
|
|
US5877218A
(en)
|
1994-01-10 |
1999-03-02 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
US7473423B2
(en)
|
1994-04-29 |
2009-01-06 |
Mayo Foundation For Medical Education And Research |
Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system
|
|
WO1997043416A1
(en)
|
1996-05-10 |
1997-11-20 |
Biogen, Inc. |
Common gamma chain blocking agents
|
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
ATE371231T1
(de)
|
1999-02-05 |
2007-09-15 |
Samsung Electronics Co Ltd |
Verfahren und vorrichtung zur wiederauffindung von texturbildern
|
|
IL158969A0
(en)
|
2001-06-01 |
2004-05-12 |
Cornell Res Foundation Inc |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
JP2005538706A
(ja)
|
2001-07-12 |
2005-12-22 |
ジェファーソン フーテ， |
スーパーヒト化抗体
|
|
EP1575480A4
(en)
|
2002-02-22 |
2008-08-06 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM
|
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
AU2003270439B2
(en)
|
2002-09-11 |
2009-09-24 |
Genentech, Inc. |
Novel composition and methods for the treatment of immune related diseases
|
|
KR101224235B1
(ko)
|
2003-04-11 |
2013-01-25 |
메디뮨 엘엘씨 |
재조합 ｉｌ９ 항체 및 그의 용도
|
|
TWI309240B
(en)
|
2004-09-17 |
2009-05-01 |
Hoffmann La Roche |
Anti-ox40l antibodies
|
|
CA2602777C
(en)
|
2005-03-25 |
2018-12-11 |
Tolerrx, Inc. |
Gitr binding molecules and uses therefor
|
|
JP5004154B2
(ja)
|
2005-04-06 |
2012-08-22 |
一般財団法人化学及血清療法研究所 |
組換え抗ボツリヌス神経毒素抗体
|
|
EP2399932B1
(en)
|
2005-05-12 |
2016-11-16 |
ZymoGenetics, Inc. |
Compositions and methods for modulating immune responses
|
|
US7736647B2
(en)
|
2005-06-15 |
2010-06-15 |
Monoclonal Antibodies Therapeutics |
Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
|
|
KR101888321B1
(ko)
|
2005-07-01 |
2018-08-13 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
|
US20070254339A1
(en)
|
2006-04-13 |
2007-11-01 |
West James W |
Tetramerizing polypeptides and methods of use
|
|
FI20075059A0
(fi)
|
2007-01-29 |
2007-01-29 |
Valtion Teknillinen |
Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus
|
|
NZ577858A
(en)
|
2007-01-29 |
2012-02-24 |
Valtion Teknillinen |
Method for producing novel ige based reagents
|
|
WO2008127735A1
(en)
|
2007-04-13 |
2008-10-23 |
Stemline Therapeutics, Inc. |
Il3ralpha antibody conjugates and uses thereof
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
DK2175884T3
(en)
|
2007-07-12 |
2016-09-26 |
Gitr Inc |
Combination USING GITR BINDING MOLECULES
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
CA2705923A1
(en)
|
2007-11-16 |
2009-05-22 |
Nuvelo, Inc. |
Antibodies to lrp6
|
|
WO2009073163A1
(en)
|
2007-12-03 |
2009-06-11 |
American Type Culture Collection (Atcc) |
Avian influenza antibodies, compositions, and methods thereof
|
|
JP5770624B2
(ja)
|
2008-04-09 |
2015-08-26 |
ジェネンテック， インコーポレイテッド |
免疫関連疾患の治療のための新規組成物と方法
|
|
WO2009154026A1
(ja)
|
2008-06-20 |
2009-12-23 |
国立大学法人岡山大学 |
石灰化小球に対する抗体及びその用途
|
|
FR2933702A1
(fr)
|
2008-07-08 |
2010-01-15 |
Sanofi Aventis |
Antagonistes specifiques du recepteur fgf-r4
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
US8183346B2
(en)
|
2008-12-05 |
2012-05-22 |
Eli Lilly And Company |
Anti-ferroportin 1 monoclonal antibodies and uses thereof
|
|
US8217149B2
(en)
|
2008-12-09 |
2012-07-10 |
Genentech, Inc. |
Anti-PD-L1 antibodies, compositions and articles of manufacture
|
|
ES2641612T3
(es)
|
2009-04-17 |
2017-11-10 |
Immunas Pharma, Inc. |
Anticuerpos que se unen específicamente a oligómeros de beta A y uso de los mismos
|
|
JP5769316B2
(ja)
|
2009-08-06 |
2015-08-26 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
US9476887B2
(en)
|
2009-08-18 |
2016-10-25 |
National Research Council Of Canada |
Screening of protein candidates
|
|
SG178991A1
(en)
|
2009-09-03 |
2012-04-27 |
Schering Corp |
Anti-gitr antibodies
|
|
JP2013508287A
(ja)
|
2009-10-14 |
2013-03-07 |
ヤンセン バイオテツク，インコーポレーテツド |
抗体を親和性成熟する方法
|
|
SI2949670T1
(sl)
|
2009-12-10 |
2019-05-31 |
F. Hoffmann-La Roche Ag |
Protitelesa, ki se preferenčno vežejo na zunajcelično domeno 4 človeškega CSF1R, in njihova uporaba
|
|
CN102869680B
(zh)
|
2010-02-26 |
2016-10-05 |
生命北极神经科学公司 |
原细纤维结合抗体及其在帕金森氏症、路易体痴呆和其他α-共核蛋白病的治疗和诊断方法中的应用
|
|
SG10201604336VA
(en)
|
2010-03-04 |
2016-07-28 |
Macrogenics Inc |
Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
|
|
MX2012010014A
(es)
|
2010-03-05 |
2012-09-21 |
Hoffmann La Roche |
Anticuerpos contra csf-1r humano y sus usos.
|
|
JP5989547B2
(ja)
|
2010-03-05 |
2016-09-07 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ヒトｃｓｆ−１ｒに対する抗体及びその使用
|
|
FR2959416B1
(fr)
|
2010-05-03 |
2012-06-22 |
Monoclonal Antibodies Therapeutics Mat Biopharma |
Utilisation d'anticorps anti-cd71 pour la preparation d'un medicament
|
|
ES2706412T3
(es)
|
2010-05-04 |
2019-03-28 |
Five Prime Therapeutics Inc |
Anticuerpos que se unen a CSF1R
|
|
WO2011156356A1
(en)
|
2010-06-09 |
2011-12-15 |
Zymogenetics, Inc. |
Dimeric vstm3 fusion proteins and related compositions and methods
|
|
JP2012021943A
(ja)
|
2010-07-16 |
2012-02-02 |
National Cancer Center |
子宮体がんの検査方法、子宮体がんの検査薬、並びに子宮体がん抗原に対する抗体
|
|
AU2011289234B2
(en)
|
2010-08-13 |
2014-09-11 |
Baylor Research Institute |
Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
|
|
CA2810359C
(en)
|
2010-09-09 |
2021-06-22 |
Pfizer Inc. |
4-1bb binding molecules
|
|
US8962804B2
(en)
|
2010-10-08 |
2015-02-24 |
City Of Hope |
Meditopes and meditope-binding antibodies and uses thereof
|
|
EP2632490A4
(en)
|
2010-10-29 |
2014-10-22 |
Immunogen Inc |
NOVEL MOLECULES BINDING TO THE EGF RECEPTOR AND IMMUNOCONJUGATES THEREOF
|
|
WO2012078793A2
(en)
|
2010-12-07 |
2012-06-14 |
Board Of Regents, The University Of Texas System |
Methods and compositions related to tazarotene-induced gene 1 (tig1)
|
|
PE20140673A1
(es)
|
2010-12-08 |
2014-06-14 |
Stem Centrx Inc |
Nuevos moduladores y metodos para su uso
|
|
AR085633A1
(es)
|
2011-03-08 |
2013-10-16 |
Baylor Res Inst |
Coadyuvantes basados en anticuerpos que son dirigidos directamente a las celulas presentadoras en antigenos
|
|
WO2012129227A1
(en)
|
2011-03-22 |
2012-09-27 |
Baylor Research Institute |
Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine
|
|
EP2688592A4
(en)
|
2011-03-25 |
2015-07-22 |
Baylor Res Inst |
Compositions and methods for immunization against the hepatitis C virus
|
|
ES2669310T3
(es)
|
2011-04-20 |
2018-05-24 |
Medimmune, Llc |
Anticuerpos y otras moléculas que se unen con B7-H1 y PD-1
|
|
US9127061B2
(en)
|
2011-06-24 |
2015-09-08 |
Perseus Proteomics Inc. |
Anti-human P-cadherin (CDH3) recombinant antibody
|
|
LT2785375T
(lt)
|
2011-11-28 |
2020-11-10 |
Merck Patent Gmbh |
Anti-pd-l1 antikūnai ir jų panaudojimas
|
|
MX356337B
(es)
|
2011-12-15 |
2018-05-23 |
Hoffmann La Roche |
Anticuerpos contra csf-1r humano y sus usos.
|
|
CN104093740B
(zh)
|
2012-02-06 |
2018-01-09 |
弗·哈夫曼-拉罗切有限公司 |
使用csf1r抑制剂的组合物和方法
|
|
MX360208B
(es)
|
2012-02-21 |
2018-10-24 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
|
|
CA2864869C
(en)
|
2012-02-21 |
2021-10-19 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
|
SG11201405130UA
(en)
|
2012-02-24 |
2014-11-27 |
Stemcentrx Inc |
Anti sez6 antibodies and methods of use
|
|
SMT201700467T1
(it)
*
|
2012-02-24 |
2017-11-15 |
Abbvie Stemcentrx Llc |
Modulatori di dll3 e metodi di uso
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
KR102052400B1
(ko)
|
2012-03-30 |
2019-12-06 |
도레이 카부시키가이샤 |
담낭암의 치료 및/또는 예방용 의약 조성물
|
|
MX358224B
(es)
|
2012-03-30 |
2018-08-10 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion de cancer de higado.
|
|
EP2834271B1
(en)
|
2012-04-03 |
2019-01-16 |
NovelMed Therapeutics, Inc. |
Humanized and chimeric anti-factor bb antibodies and uses thereof
|
|
KR20150003251A
(ko)
|
2012-04-04 |
2015-01-08 |
가부시키가이샤 페르세우스 프로테오믹스 |
항 cdh3(p-카드헤린) 항체의 약물 콘쥬게이트
|
|
KR20150018533A
(ko)
|
2012-05-11 |
2015-02-23 |
파이브 프라임 테라퓨틱스, 인크. |
콜로니 자극 인자 1 수용체(csf1r)에 결속하는 항체들에 의한 질병 상태의 치료 방법
|
|
WO2013172961A1
(en)
|
2012-05-14 |
2013-11-21 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
KR20150018604A
(ko)
|
2012-06-06 |
2015-02-23 |
온코메드 파마슈티칼스, 인크. |
히포 경로를 조절하는 결합제 및 그의 용도
|
|
UY34887A
(es)
|
2012-07-02 |
2013-12-31 |
Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware |
Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
|
|
KR20150047593A
(ko)
|
2012-08-31 |
2015-05-04 |
파이브 프라임 테라퓨틱스, 인크. |
집락 자극 인자 1 수용체(csf1r)에 결합하는 항체로 질환을 치료하는 방법
|
|
SMT201900242T1
(it)
|
2012-12-03 |
2019-05-10 |
Bristol Myers Squibb Co |
Incremento dell'attivita' anti-cancro di proteine di fuzione a fc immunomodulatrici
|
|
CA2892831A1
(en)
|
2012-12-04 |
2014-06-12 |
Oncomed Pharmaceuticals, Inc. |
Immunotherapy with binding agents
|
|
IL242088B2
(en)
|
2013-05-20 |
2023-12-01 |
Genentech Inc |
Anti-transferrin receptor antibodies and methods of use
|
|
US10364288B2
(en)
|
2013-05-24 |
2019-07-30 |
Biogen Ma Inc. |
Anti-GPIIB/IIIA antibodies or uses thereof
|
|
TW201536811A
(zh)
|
2013-05-31 |
2015-10-01 |
Biogen Idec Inc |
嵌合ｆｖｉｉ－ｘｔｅｎ分子及其用途
|
|
SG11201600310QA
(en)
|
2013-07-16 |
2016-02-26 |
Genentech Inc |
Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors
|
|
JP2015066079A
(ja)
|
2013-09-27 |
2015-04-13 |
オリンパス株式会社 |
超音波処置具、及び手術システム
|
|
PE20210107A1
(es)
|
2013-12-17 |
2021-01-19 |
Genentech Inc |
Anticuerpos anti-cd3 y metodos de uso
|
|
EP3086809A4
(en)
|
2013-12-24 |
2017-11-29 |
NovelMed Therapeutics, Inc. |
Compositions and methods of treating ocular diseases
|
|
TWI681969B
(zh)
|
2014-01-23 |
2020-01-11 |
美商再生元醫藥公司 |
針對ｐｄ-１的人類抗體
|
|
TWI680138B
(zh)
|
2014-01-23 |
2019-12-21 |
美商再生元醫藥公司 |
抗ｐｄ-ｌ１之人類抗體
|
|
JOP20200094A1
(ar)
|
2014-01-24 |
2017-06-16 |
Dana Farber Cancer Inst Inc |
جزيئات جسم مضاد لـ pd-1 واستخداماتها
|
|
JOP20200096A1
(ar)
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
جزيئات جسم مضاد لـ tim-3 واستخداماتها
|
|
KR101740030B1
(ko)
|
2014-03-07 |
2017-05-29 |
사회복지법인 삼성생명공익재단 |
ScFv 항체 라이브러리, 이의 제조방법 및 이를 이용한 ScFv 항체 스크리닝 방법
|
|
CA2936962C
(en)
|
2014-03-14 |
2024-03-05 |
Novartis Ag |
Antibody molecules to lag-3 and uses thereof
|
|
JP6588461B2
(ja)
|
2014-03-31 |
2019-10-09 |
ジェネンテック， インコーポレイテッド |
抗血管新生剤及びｏｘ４０結合アゴニストを含む併用療法
|
|
SG10201811841UA
(en)
|
2014-07-16 |
2019-02-27 |
Genentech Inc |
Methods of treating cancer using tigit inhibitors and anti-cancer agents
|
|
MX391141B
(es)
|
2014-08-07 |
2025-03-21 |
Memorial Sloan Kettering Cancer Center |
Anticuerpos anti-ceramida.
|
|
JO3664B1
(ar)
*
|
2014-08-19 |
2020-08-27 |
Merck Sharp & Dohme |
أجسام مضادة لـ tigit
|
|
KR20170072343A
(ko)
|
2014-11-06 |
2017-06-26 |
제넨테크, 인크. |
Ox40 결합 효능제 및 tigit 억제제를 포함하는 병용 요법
|
|
US10508151B2
(en)
|
2014-11-19 |
2019-12-17 |
Genentech, Inc. |
Anti-transferrin receptor antibodies and methods of use
|
|
JP6993228B2
(ja)
|
2014-11-19 |
2022-03-03 |
ジェネンテック， インコーポレイテッド |
抗トランスフェリン受容体／抗ｂａｃｅ１多重特異性抗体および使用方法
|
|
CN110256558B
(zh)
|
2014-12-23 |
2023-07-04 |
百时美施贵宝公司 |
针对tigit的抗体
|
|
TWI715587B
(zh)
|
2015-05-28 |
2021-01-11 |
美商安可美德藥物股份有限公司 |
Ｔｉｇｉｔ結合劑和彼之用途
|
|
KR20230125094A
(ko)
*
|
2015-09-25 |
2023-08-28 |
제넨테크, 인크. |
항-tigit 항체 및 이의 이용 방법
|
|
JP7023233B2
(ja)
|
2015-10-01 |
2022-02-21 |
ポテンザ セラピューティックス インコーポレイテッド |
抗ｔｉｇｉｔ抗原結合タンパク質と、その使用方法
|
|
UA124529C2
(uk)
|
2016-01-08 |
2021-10-05 |
Аркус Байосайєнсіз, Інк. |
Модулятори екто-5-нуклеотидази та їх застосування
|
|
TWI805127B
(zh)
|
2016-03-04 |
2023-06-11 |
美商Ｊｎ生物科學有限責任公司 |
針對tigit之抗體
|
|
DK3347379T5
(da)
*
|
2016-08-17 |
2020-06-15 |
Compugen Ltd |
Anti-tigit-antistoffer, anti-pvrig-antistoffer og kombinationer deraf
|
|
WO2018067424A1
(en)
|
2016-10-03 |
2018-04-12 |
Arcus Biosciences, Inc. |
Inhibitors of adenosine 5'-nucleotidase
|
|
CN110022881B
(zh)
|
2016-11-18 |
2023-05-02 |
艾库斯生物科学有限公司 |
Cd73介导的免疫抑制的抑制剂
|
|
EP4310082A3
(en)
|
2017-01-20 |
2024-04-10 |
Arcus Biosciences, Inc. |
Azolopyrimidine for the treatment of cancer-related disorders
|
|
KR102745835B1
(ko)
*
|
2017-02-27 |
2024-12-24 |
샤턱 랩스 인코포레이티드 |
Tigit- 및 light-기반 키메라 단백질
|
|
SG10202103227YA
(en)
|
2017-02-28 |
2021-04-29 |
Seattle Genetics Inc |
Anti-tigit antibodies
|
|
US20200354453A1
(en)
*
|
2017-05-02 |
2020-11-12 |
Merck Sharp & Dohme Corp. |
Stable formulations of anti-tigit antibodies alone and in combination with programmed death receptor 1 (pd-1) antibodies and methods of use thereof
|
|
WO2018204661A1
(en)
|
2017-05-05 |
2018-11-08 |
Arcus Biosciences, Inc. |
Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
|
|
GB201709808D0
(en)
|
2017-06-20 |
2017-08-02 |
Kymab Ltd |
Antibodies
|
|
WO2019023504A1
(en)
|
2017-07-27 |
2019-01-31 |
Iteos Therapeutics Sa |
ANTI-TIGIT ANTIBODIES
|
|
TWI816729B
(zh)
|
2017-12-30 |
2023-10-01 |
英屬開曼群島商百濟神州有限公司 |
抗tigit抗體及其作為治療和診斷的用途
|
|
WO2019154415A1
(en)
*
|
2018-02-06 |
2019-08-15 |
I-Mab |
Antibodies to t cell immunoreceptor with ig and itim domains (tigit) and uses thereof
|
|
CN112135626B
(zh)
|
2018-07-25 |
2023-05-23 |
信达生物制药(苏州)有限公司 |
抗tigit抗体及其用途
|
|
EP3841123A2
(en)
|
2018-08-23 |
2021-06-30 |
Seagen Inc. |
Anti-tigit antibodies
|
|
CN109384846B
(zh)
*
|
2018-09-25 |
2020-03-03 |
合肥瑞达免疫药物研究所有限公司 |
能够结合tigit的抗体或其抗原结合片段及用途
|
|
KR102718333B1
(ko)
|
2018-11-16 |
2024-10-17 |
아르커스 바이오사이언시즈 인코포레이티드 |
Arg1 및/또는 arg2의 억제제
|
|
CN111196852A
(zh)
|
2018-11-16 |
2020-05-26 |
四川科伦博泰生物医药股份有限公司 |
抗tigit抗体及其用途
|
|
EP3908609A1
(en)
|
2019-01-07 |
2021-11-17 |
iTeos Belgium SA |
Anti-tigit antibodies
|
|
JP7665534B2
(ja)
|
2019-06-04 |
2025-04-21 |
アーカス バイオサイエンシーズ インコーポレイテッド |
２，３，５－三置換ピラゾロ［１，５－ａ］ピリミジン化合物
|
|
CN113840840A
(zh)
|
2019-06-13 |
2021-12-24 |
株式会社绿十字 |
Tigit抗体及其用途
|
|
KR20220042258A
(ko)
|
2019-07-15 |
2022-04-04 |
상하이 준스 바이오사이언스 컴퍼니 리미티드 |
항 tigit 항체 및 그의 응용
|
|
AU2021284273A1
(en)
|
2020-06-02 |
2022-12-15 |
Arcus Biosciences, Inc. |
Antibodies to TIGIT
|